Can-Fite BioPharma Ltd. (CANF) Stock Price History
Historical prices from 2012 to 2026
Loading 10-year price history...
CANF Historical Performance
Short-Term Returns
CANF Stock Price Trajectory (2012–2026)
As of May 7, 2026, Can-Fite BioPharma Ltd. (CANF) trades at $3.49, representing a +220.2% return over the past year. The stock has delivered a -82.5% total return over five years (-29.4% CAGR), reflecting challenging market conditions.
The stock reached its all-time high of $1,419.00 on December 23, 2013. From this peak, CANF has corrected -99.8%, currently trading 54% below its 200-day moving average, suggesting potential weakness.
When compared to Healthcare sector peers RCUS (+220.2% 1Y), PRAX (+860.9% 1Y), and ACAD (+47.7% 1Y), CANF has underperformed the peer group average. Compare CANF vs RCUS →
CANF Historical Price Data (2012–2026)
Showing 30 of 3,395 records| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-05-06 | 3.56 | 3.71 | 3.41 | 3.49 | 80K | -7.79% |
| 2026-05-05 | 3.08 | 3.90 | 3.08 | 3.79 | 140K | +11.32% |
| 2026-05-04 | 2.96 | 3.42 | 2.88 | 3.40 | 452K | +16.04% |
| 2026-05-01 | 3.24 | 3.24 | 2.89 | 2.93 | 534K | -8.15% |
| 2026-04-30 | 3.65 | 4.08 | 2.87 | 3.19 | 27.08M | +8.14% |
| 2026-04-29 | 2.90 | 3.01 | 2.83 | 2.95 | 26K | +1.37% |
| 2026-04-28 | 2.98 | 2.98 | 2.90 | 2.91 | 10K | -0.34% |
| 2026-04-27 | 2.95 | 3.03 | 2.90 | 2.92 | 15K | +0.17% |
| 2026-04-24 | 2.97 | 3.04 | 2.88 | 2.92 | 18K | +0.17% |
| 2026-04-23 | 3.04 | 3.04 | 2.90 | 2.91 | 16K | -1.69% |
| 2026-04-22 | 2.94 | 3.01 | 2.90 | 2.96 | 15K | -0.34% |
| 2026-04-21 | 3.03 | 3.03 | 2.87 | 2.97 | 39K | -1.00% |
| 2026-04-20 | 3.00 | 3.16 | 2.97 | 3.00 | 24K | -1.32% |
| 2026-04-17 | 3.10 | 3.16 | 2.94 | 3.04 | 32K | -3.18% |
| 2026-04-16 | 3.08 | 3.16 | 3.07 | 3.14 | 13K | -0.95% |
| 2026-04-15 | 3.07 | 3.24 | 3.03 | 3.17 | 34K | +3.93% |
| 2026-04-14 | 3.12 | 3.12 | 3.02 | 3.05 | 29K | +4.45% |
| 2026-04-13 | 2.93 | 3.10 | 2.91 | 2.92 | 39K | 0.00% |
| 2026-04-10 | 2.98 | 3.06 | 2.90 | 2.92 | 13K | -0.34% |
| 2026-04-09 | 3.07 | 3.16 | 2.93 | 2.93 | 56K | -4.40% |
| 2026-04-08 | 3.10 | 3.10 | 3.04 | 3.06 | 16K | +1.16% |
| 2026-04-07 | 3.05 | 3.12 | 3.01 | 3.03 | 21K | -5.31% |
| 2026-04-06 | 3.18 | 3.23 | 3.10 | 3.20 | 20K | +4.23% |
| 2026-04-02 | 2.98 | 3.12 | 2.98 | 3.07 | 23K | -0.65% |
| 2026-04-01 | 3.03 | 3.21 | 2.96 | 3.09 | 15K | -0.32% |
| 2026-03-31 | 2.98 | 3.10 | 2.95 | 3.10 | 45K | +2.99% |
| 2026-03-30 | 3.13 | 3.21 | 3.01 | 3.01 | 46K | -4.14% |
| 2026-03-27 | 3.27 | 3.29 | 3.14 | 3.14 | 33K | -7.37% |
| 2026-03-26 | 3.23 | 3.39 | 3.20 | 3.39 | 23K | +4.95% |
| 2026-03-25 | 3.18 | 3.33 | 3.15 | 3.23 | 35K | +3.19% |
See CANF's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CANF Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare CANF vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonCANF — Frequently Asked Questions
Quick answers to the most common questions about buying CANF stock.
How has CANF stock performed recently?
CANF returned +220.2% over the past year, beating its 5-year annualized CAGR of -29.4%. The stock trades below its 200-day moving average, confirming the uptrend.
What is CANF's all-time high price?
Can-Fite BioPharma Ltd. reached $1419.00 on 2013-12-23. The 52-week high is $10.40. Current 1-year return of +220.2% places the stock closer to historical peaks.
Where can I download CANF historical price data?
This page provides CANF daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2012-2026, downloadable in CSV format.